Hainan Shuangcheng Pharmaceut (002693) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has a cash flow conversion efficiency ratio of 0.083x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.67 Million ≈ $4.93 Million USD) by net assets (CN¥404.35 Million ≈ $59.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Hainan Shuangcheng Pharmaceut - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how Hainan Shuangcheng Pharmaceut's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002693 current and long-term liabilities for a breakdown of total debt and financial obligations.
Hainan Shuangcheng Pharmaceut Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Rutong Petro-Machinery
SHG:603036
|
0.044x |
|
Electra Co Pr
TA:ECP
|
0.097x |
|
Jana Small Finance Bank
NSE:JSFB
|
-0.220x |
|
Zhejiang Tiantai Xianghe Industrial Co Ltd
SHG:603500
|
0.009x |
|
Anhui Xinbo Aluminum Co Ltd
SHE:003038
|
-0.140x |
|
Nanjing Railway New Technology Co.Ltd.
SHE:301016
|
0.031x |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
0.036x |
|
Beijing Haohan Data Technology Co. Ltd. A
SHG:688292
|
N/A |
Annual Cash Flow Conversion Efficiency for Hainan Shuangcheng Pharmaceut (2009–2024)
The table below shows the annual cash flow conversion efficiency of Hainan Shuangcheng Pharmaceut from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see 002693 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥411.61 Million ≈ $60.23 Million |
CN¥-40.83 Million ≈ $-5.97 Million |
-0.099x | -541.12% |
| 2023-12-31 | CN¥517.65 Million ≈ $75.75 Million |
CN¥11.64 Million ≈ $1.70 Million |
0.022x | -48.20% |
| 2022-12-31 | CN¥580.94 Million ≈ $85.01 Million |
CN¥25.22 Million ≈ $3.69 Million |
0.043x | +4.45% |
| 2021-12-31 | CN¥566.75 Million ≈ $82.93 Million |
CN¥23.55 Million ≈ $3.45 Million |
0.042x | +336.77% |
| 2020-12-31 | CN¥598.31 Million ≈ $87.55 Million |
CN¥-10.50 Million ≈ $-1.54 Million |
-0.018x | -117.88% |
| 2019-12-31 | CN¥678.26 Million ≈ $99.25 Million |
CN¥66.58 Million ≈ $9.74 Million |
0.098x | +40.36% |
| 2018-12-31 | CN¥669.69 Million ≈ $98.00 Million |
CN¥46.84 Million ≈ $6.85 Million |
0.070x | +336.39% |
| 2017-12-31 | CN¥761.71 Million ≈ $111.46 Million |
CN¥-22.54 Million ≈ $-3.30 Million |
-0.030x | -142.35% |
| 2016-12-31 | CN¥553.13 Million ≈ $80.94 Million |
CN¥38.65 Million ≈ $5.66 Million |
0.070x | +40.17% |
| 2015-12-31 | CN¥927.61 Million ≈ $135.74 Million |
CN¥46.24 Million ≈ $6.77 Million |
0.050x | -12.67% |
| 2014-12-31 | CN¥893.55 Million ≈ $130.75 Million |
CN¥51.00 Million ≈ $7.46 Million |
0.057x | -11.95% |
| 2013-12-31 | CN¥870.62 Million ≈ $127.40 Million |
CN¥56.43 Million ≈ $8.26 Million |
0.065x | -31.65% |
| 2012-12-31 | CN¥845.85 Million ≈ $123.77 Million |
CN¥80.22 Million ≈ $11.74 Million |
0.095x | -67.23% |
| 2011-12-31 | CN¥228.23 Million ≈ $33.40 Million |
CN¥66.05 Million ≈ $9.67 Million |
0.289x | -17.45% |
| 2010-12-31 | CN¥157.82 Million ≈ $23.09 Million |
CN¥55.33 Million ≈ $8.10 Million |
0.351x | -38.27% |
| 2009-12-31 | CN¥77.95 Million ≈ $11.41 Million |
CN¥44.27 Million ≈ $6.48 Million |
0.568x | -- |
About Hainan Shuangcheng Pharmaceut
Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmace… Read more